average selling price decreased considerably due to slowdown in Thai economy, strengthening of Thai Baht, and surge in imports of Alloy Steel and Galvanised HRC post expiry of safeguard duties. While total
decrease in total consumption coupled with surge in imports led to 22% decrease in Domestic production compared with 2018. As per Iron Steel Institution of Thailand (ISIT) the Domestic capacity utilization
last year, while gross profit margin was slightly strengthened from 6.83% in 1H/2016 to 7.89% in 1H/2017. Other income in 1H/2017 amounted to Baht 741.35 million, a surge by Baht 375.49 million or 102.63
) -45% 10% Profit attributable to owners of parent 1,168 (1,546) 214 -82% 114% Basic earnings per share (Baht) 0.85 (1.12) 0.16 Note: 1/ EBITDA from Refinery Business of the Company, BCP Trading Pte. Ltd
increased ,as well as the Social security revenue of subsidiaries increased due to Social Security Office has increase the basic capitation payment rate in year 2020 . 2. Cost of hospital operations increased
general patient decreased. However Social security revenue of subsidiaries increased due to the increase of the basic capitation payment rate in year 2020. 2. Cost of hospital operations & Administrative
, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 2. Costs of sales and gross profit Costs of sales were Baht 117 .60 million in the first nine months of 2019, a surge of Baht 32 .42 million
had a loss for the year 2018 amounted to 164.99 million Baht, basic loss per share was equal to 0.27 Baht per share. From the year 2017, the company had a loss of 86.78 million Baht. Basic loss per
same period of last year Q2-2016. Company Name The employee benefit obligation * Old Basic Information The employee benefit obligation * New Basic Information Different from The employee benefit
related corporate tax transaction, the normalized net profit would be approximately THB 97.42 million or a surge of 48% yoy. Page 3 of 4 Statement of Financial Position as of March 31, 2019 The consolidated